Hainan Boao Lecheng

entity

Last mentioned: Mar 7, 2026

Timeline

  1. Annual Progress Review

    First assessment of the 15th Five-Year Plan's initial biotech milestones.

  2. R&D Tax Incentive Launch

    Specialized tax breaks for high-tech biotech firms are rolled out nationwide.

  3. NMPA Reform Implementation

    New guidelines for accelerated clinical trial approvals take effect.

  4. Policy Framework Unveiled

    China details the 2026 policy mix focusing on innovation and global sharing.

Stories mentioning Hainan Boao Lecheng 1

pharma Bullish

China Unveils 2026 Innovation Roadmap: A New Era for Biotech Globalism

China has detailed a comprehensive 2026 policy framework aimed at accelerating domestic biotech innovation while expanding international market access. The initiative prioritizes 'new quality productive forces' in drug development and streamlines regulatory pathways for global pharmaceutical collaborations.

2 sources